Pharmacokinetic considerations in seasonal malaria chemoprevention
African children under 5 years of age bear the main burden of global malaria mortality. Seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaquine (AQ) given monthly during the rainy season is a highly effective malaria intervention for children aged between 3 months...
Saved in:
Main Authors: | Palang Chotsiri, Nicholas J. White, Joel Tarning |
---|---|
Other Authors: | Faculty of Tropical Medicine, Mahidol University |
Format: | Review |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/74090 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Pharmacokinetic considerations in seasonal malaria chemoprevention
by: Chotsiri P.
Published: (2023) -
Seasonal malaria chemoprevention: Successes and missed opportunities
by: Matthew E. Coldiron, et al.
Published: (2018) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Palang Chotsiri, et al.
Published: (2020) -
Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children
by: Junjie Ding, et al.
Published: (2020) -
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
by: Kris M. Jamsen, et al.
Published: (2018)